Psychomotor and Anxiolytic Effects of Mexazolam in Patients with Generalised Anxiety Disorder

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.4, 2003-01, pp. : 235-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mexazolam and Alprazolam in the Treatment of Generalised Anxiety Disorder: A Double-Blind, Randomised Clinical Trial

By Vaz-Serra A.

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Psychomotor Effects of Mexazolam vs Placebo in Healthy Volunteers

By Silveira P. Vaz-da-Silva M. Dolgner A. Almeida L.

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 677-684

Adis International

Access to resources Recommend Favorite

Generalised Anxiety Disorder in Elderly Patients: Epidemiology, Diagnosis and Treatment Options

By Alastair J. Flint

Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. : 101-114

Adis International

Access to resources Recommend Favorite

Pregabalin: In the Treatment of Generalised Anxiety Disorder

By Frampton James E. Foster Rachel H.

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 685-693

Adis International

Access to resources Recommend Favorite

Generalised Anxiety Disorder: Treatment Options

By Sramek J.J.

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1635-1648

Adis International

Access to resources Recommend Favorite